Hudson Bay Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-30,000
Closed -$1.79M 714
2018
Q4
$1.79M Sell
30,000
-5,100
-15% -$319K 0.02% 541
2018
Q3
$2.35M Buy
+35,100
New +$2.34M 0.03% 429
2017
Q4
Sell
-250,000
Closed -$18.2M 496
2017
Q3
$18.2M Sell
250,000
-15,300
-6% -$1.1M 0.45% 46
2017
Q2
$19.7M Buy
265,300
+76,800
+41% +$5.7M 0.4% 55
2017
Q1
$13.8M Buy
188,500
+158,500
+528% +$11.1M 0.19% 114
2016
Q4
$1.96M Sell
30,000
-8,600
-22% -$590K 0.04% 357
2016
Q3
$2.86M Sell
38,600
-100,000
-72% -$7.39M 0.07% 195
2016
Q2
$10.1M Buy
+138,600
New +$9.87M 0.31% 55

Other funds holding CL

Hudson Bay Capital Management's CL Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 207,331 shares — an estimated $16.4M sold.

Hudson Bay Capital Management first reported a position in CL in Q4 2016 and held it in 19 quarters. The position peaked at $21M in Q4 2023. 1,949 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 207,331 Colgate-Palmolive shares in Q1 2026, an estimated $16.4M.
  • Hudson Bay Capital Management first reported a position in Colgate-Palmolive in Q4 2016 and held it in 19 quarters.
  • Hudson Bay Capital Management's Colgate-Palmolive position peaked at $21M in Q4 2023.
  • 1,949 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.